PipelinePharma Logo
PipelinePharma Logo
Marketplace
Sign in Get started

Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-054 manufacturers

Filters

None products found

pp-054

Tablets

Dossier type
US CTD
Dossier status
Under development
Country of origin
United States
Comments
Indication: Early Alzheimer’s disease, with a therapeutic focus on patients carrying the APOE4 genotype, especially APOE4 homozygotes who represent the highest-risk population for amyloid-driven neurodegeneration. Clinical stage: Phase 3 following positive Phase 2 biomarker and cognitive outcomes; Fast Track designation in the U.S. Modality: Small molecule (oral) Mechanism / Target: prevents amyloid-β (Aβ) oligomer formation and neurotoxicity by stabilizing Aβ monomers in the brain, thereby reducing downstream synaptic injury and cognitive decline. Route / form: Oral tablets (BID dosing, commercialy ready) Differentiation: First oral anti-amyloid oligomer inhibitor targeting genetically defined Alzheimer’s patients; avoids infusion-related risks and ARIA complications associated with monoclonal antibodies; strong biomarker effect and favorable safety profile make it a promising precision-medicine option for APOE4 carriers.
Manufacturer #38612

A clinical-stage biopharmaceutical company focused on developing oral small molecules to treat Alzheimer’s and other neurodegenerative disorders. It advances precision-targeted therapies through rigorous research and global development efforts. The organization pursues strategic partnerships to broaden patient impact.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.